Table 2.
Outcomes of Patients With and Without Post‐TAVR PPMI
| In‐Hospital Outcome | TAVR Without PPMI (n=69 527) | TAVR With PPMI (n=7878) | P Value |
|---|---|---|---|
| Death | 2.6 | 1.8 | <0.001 |
| Acute ischemia stroke | 1.2 | 1.2 | 0.55 |
| Acute kidney injury | 13.1 | 19.0 | <0.001 |
| AKI requiring dialysis | 1.0 | 1.2 | 0.048 |
| Blood transfusion | 12.0 | 15.1 | <0.001 |
| Vascular complication | 3.7 | 3.8 | 0.45 |
| Tamponade | 0.9 | 1.6 | <0.001 |
| Gastrointestinal bleed | 1.3 | 1.4 | 0.41 |
| Mechanical ventilation | 3.0 | 4.0 | <0.001 |
| Length of stay, median (IQR) | 3 (2–7) | 6 (4–9) | <0.001 |
| Hospital cost, USD, median (IQR) | 47 661 (37 304–62 244) | 63 471 (50 925–80 709) | <0.001 |
| Length of stay >5 d | 31.9 | 51.8 | <0.001 |
| Discharged to a facility | 16.6 | 27.3 | <0.001 |
Data are percentages except as noted. AKI indicates acute kidney injury; IQR, interquartile range; PPMI, permanent pacemaker implantation; TAVR, transcatheter aortic valve replacement; USD, US dollars.